Regen BioPharma Inc (RGBP)
0.70
-0.04
(-5.41%)
USD |
OTCM |
Apr 26, 16:00
Regen BioPharma Max Drawdown (5Y): 100.00% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 100.00% |
March 31, 2023 | 100.00% |
February 28, 2023 | 100.00% |
January 31, 2023 | 100.00% |
December 31, 2022 | 100.00% |
November 30, 2022 | 100.00% |
October 31, 2022 | 100.00% |
September 30, 2022 | 100.00% |
August 31, 2022 | 100.00% |
July 31, 2022 | 100.00% |
June 30, 2022 | 100.00% |
May 31, 2022 | 100.00% |
April 30, 2022 | 100.00% |
March 31, 2022 | 100.00% |
Date | Value |
---|---|
February 28, 2022 | 100.00% |
January 31, 2022 | 100.00% |
December 31, 2021 | 100.00% |
November 30, 2021 | 100.00% |
October 31, 2021 | 100.00% |
September 30, 2021 | 100.00% |
August 31, 2021 | 100.00% |
July 31, 2021 | 100.00% |
June 30, 2021 | 100.00% |
May 31, 2021 | 100.00% |
April 30, 2021 | 100.00% |
March 31, 2021 | 100.00% |
February 28, 2021 | 100.00% |
January 31, 2021 | 100.00% |
December 31, 2020 | 100.00% |
November 30, 2020 | 100.00% |
October 31, 2020 | 100.00% |
September 30, 2020 | 100.00% |
August 31, 2020 | 100.00% |
July 31, 2020 | 100.00% |
June 30, 2020 | 100.00% |
May 31, 2020 | 100.00% |
April 30, 2020 | 100.00% |
March 31, 2020 | 100.00% |
February 29, 2020 | 99.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.74%
Minimum
Apr 2019
100.00%
Maximum
Mar 2020
99.98%
Average
100.00%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
CervoMed Inc | 99.96% |
GlucoTrack Inc | 98.90% |
AIM ImmunoTech Inc | 99.76% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -55.95 |
Beta (5Y) | 2.708 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 2.31K% |
Historical Sharpe Ratio (5Y) | -0.0089 |
Historical Sortino (5Y) | -0.3124 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 54.06% |